Clinical Trial Update: Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intradermal hepatitis B vaccine boost after IMIQUIMOD in cirrhotic patients who failed standard vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatitis Vaccination Failure

Drugs mentioned

• Imiquimod (imiquimod)
• hepatitis B vaccine (intrademal) (hepatitis B vaccine)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cirrhosis, Liver, Vaccination Failure | Phase 2 | Status: UNKNOWN